BackgroundCheck.run
Search For

Chunying Li810 Washington Ave, Memphis, TN 38105

Chunying Li Phones & Addresses

810 Washington Ave, Memphis, TN 38105    901-5272612   

810 Washington Ave #200, Memphis, TN 38105    901-5272612   

331 Fountain River Dr, Memphis, TN 38120   

41289 Heathmore Ct, Canton, MI 48187   

Mentions for Chunying Li

Chunying Li resumes & CV records

Resumes

Chunying Li Photo 12

Associate Professor

Location:
8925 Pinehurst Cv, Duluth, GA 30097
Industry:
Higher Education
Work:
Georgia State University
Associate Professor
Wayne State University May 2016 - Jun 2016
Associate Professor
Wayne State University Dec 2008 - May 2016
Assistant Professor
University of Tennessee Health Science Center May 2008 - Feb 2009
Assistant Professor
Education:
The University of Tennessee Health Science Center 2001 - 2005
Doctorates, Doctor of Philosophy, Physiology
Anhui Normal University 1990 - 1994
Bachelors, Bachelor of Science, Biology
The University of Tennessee Health Science Center
Skills:
Protein Expression, Molecular Cloning, Protein Chemistry, Microscopy, Immunofluorescence, Western Blotting
Interests:
Gpcr
Cystic Fibrosis
Inflammation
Chemokine Receptor
Protein Interaction
Cancer Biology
Chunying Li Photo 13

Chunying Li

Chunying Li Photo 14

Chunying Li

Publications & IP owners

Us Patents

Lpa2 Receptor Agonist Inhibitors Of Cftr

US Patent:
2007007, Apr 5, 2007
Filed:
Jul 19, 2006
Appl. No.:
11/489062
Inventors:
Gabor Tigyi - Memphis TN, US
Duane Miller - Germantown TN, US
Leonard Johnson - Memphis TN, US
Anjaparavanda Naren - Memphis TN, US
Chunying Li - Memphis TN, US
Wenlin Deng - Memphis TN, US
Gangadhar Durgam - Memphis TN, US
International Classification:
A61K 31/685
A61K 31/665
A61K 31/66
US Classification:
514078000, 514143000, 514100000
Abstract:
Methods and compositions for treating or preventing diarrhea are disclosed. The methods comprise administering to an individual a therapeutically effective amount of an LPAreceptor agonist for treating or preventing diarrhea. Also disclosed is a method of inhibiting CFTR activation by administering at least one LPAreceptor agonist in an amount effective to inhibit formation of a macromolecular complex between the LPAreceptor, CFTR, and a Na/H exchange regulatory factor-2 (NHERF-2).

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.